Expression of Olig2, Nestin, NogoA and AQP4 have no impact on overall survival in IDH-wildtype glioblastoma.
Despite many years of research efforts and clinical trials the prognosis of patients diagnosed with glioblastoma remains very poor. The oligodendrocyte transcription factor 2 (Olig2) was identified as a marker for glioma stem cells, which are believed to be responsible for glioma recurrence and ther...
Guardado en:
Autores principales: | Felix Behling, Alonso Barrantes-Freer, Carl Ludwig Behnes, Florian Stockhammer, Veit Rohde, Antonia Adel-Horowski, Odir Antonio Rodríguez-Villagra, Miguel Angel Barboza, Wolfgang Brück, Ulrich Lehmann, Christine Stadelmann, Christian Hartmann |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/50fde65f0bb440d99631f856de0e0b63 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
The genomic landscape of TERT promoter wildtype-IDH wildtype glioblastoma
por: Bill H. Diplas, et al.
Publicado: (2018) -
NogoA-expressing astrocytes limit peripheral macrophage infiltration after ischemic brain injury in primates
por: Anthony G. Boghdadi, et al.
Publicado: (2021) -
Newly Diagnosed IDH-Wildtype Glioblastoma and Temporal Muscle Thickness: A Multicenter Analysis
por: Tim Wende, et al.
Publicado: (2021) -
The Nestin neural enhancer is essential for normal levels of endogenous Nestin in neuroprogenitors but is not required for embryo development.
por: Ella Thomson, et al.
Publicado: (2021) -
The Nestin neural enhancer is essential for normal levels of endogenous Nestin in neuroprogenitors but is not required for embryo development
por: Ella Thomson, et al.
Publicado: (2021)